Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cencora Inc (NY: COR )

237.75 +1.44 (+0.61%)
Official Closing Price Updated: 7:00 PM EDT, Aug 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,158,996
Open 236.75
Bid (Size) 224.04 (1)
Ask (Size) 246.00 (1)
Prev. Close 236.31
Today's Range 235.00 - 238.85
52wk Range 171.65 - 247.66
Shares Outstanding 44,197,721
Dividend Yield 0.82%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Peering Into Cencora's Recent Short Interest
Via Benzinga
Health Care Giant McKesson Dives Amid Big Revenue Miss
McKesson earnings beat estimates, but the drug and health supplies distribution giant badly missed sales estimates. MCK stock dived. 
Via Investor's Business Daily
Topics Earnings
Exposures Financial

Performance

YTD
+14.01%
+14.01%
1 Month
+7.00%
+7.00%
3 Month
+7.19%
+7.19%
6 Month
+2.66%
+2.66%
1 Year
+32.90%
+32.90%

More News

Read More
Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years
Via Benzinga
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
From Cencora
Via Business Wire
Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds
From Walgreens Boots Alliance
Via Business Wire
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Via Benzinga
A Closer Look at 4 Analyst Recommendations For Cencora
Via Benzinga
COR Stock Earnings: Cencora Beats EPS, Beats Revenue for Q3 2024
Via InvestorPlace
Cencora Reports Fiscal 2024 Third Quarter Results
From Cencora
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
Via Benzinga
The 7 Most Undervalued Dividend Stocks to Buy in July 2024
Via InvestorPlace
(COR) - Analyzing Cencora's Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years
Via Benzinga
Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
From Cencora
Via Business Wire
3 Dividend Compounding Machines Poised for 30%+ Total Returns by 2026
Via InvestorPlace
Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court
Via Investor's Business Daily
3 Undervalued Gems Set to Soar 1,000% by 2026
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today
Via Benzinga
Bulletproof Your Retirement: 3 Stocks That Will Stand the Test of Time
Via InvestorPlace
Lululemon Athletica Was Among The Worst-Performing Stocks Last Week (May 19-May 26, 2024): Are These 10 Large-Cap Stock Losers In Your Portfolio?
Via Benzinga
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Via Benzinga
Topics Data Breach
Exposures Information Security
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
From Cencora
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.